Everolimus from ABBEXA LTD
Search, find, compare suppliers for Everolimus products.
| Edit | |
|---|---|
| Product Name | Everolimus |
| Description | Everolimus is a small molecule which can act as a mTOR inhibitor. It is provided as a powder. This product acts on the following target types: Kinase. This product acts on the following biochemical pathways: mTOR. This product may be of interest in the following research areas and diseases: Immunology, Cancer, Diabetes. This product may act as a Coronavirus inhibitor: Inhibits SARS-CoV in silico, and MERS-CoV in cells. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 958.25 g/mol |
| Size | 5 mg, 25 mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | Everolimus, 40-O-(2-Hydroxyethyl)rapamycin, SDZ RAD, RAD001, 159351-69-6 |
| Gene, Accession, CAS # | CAS: 159351-69-6 |
| Catalog # | abx282529 |
| Price | please inquire |
| Order / More Info | Everolimus from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Products